Cyclized derivatives as Eg-5 inhibitors
The present invention relates to new substituted imidazole compounds have the following Formula (I) and to the pharmaceutically acceptable salts, esters, or prodrugs thereof, to compositions of the compounds together with pharmaceutically acceptable carriers, and to uses of the compounds:
Novartis Vaccines and Diagnostics, Inc.
C A A A A C
C07D A61P A61P A61P A61P C07D
inventional inventional inventional inventional inventional inventional
Eric Rustum Paul A. Hong Weibo
Martin Boyce Barsanti Yang Wang